📣 VC round data is live. Check it out!
- Public Comps
- Claritev
Claritev Valuation Multiples
Discover Claritev's revenue and EBITDA valuation multiples, acquisitions, and investment history, alongside public comparables like Weave Communications, Heren Health, GPI Group, Veradigm and more.
Claritev Overview
About Claritev
Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.
Founded
2019
HQ

Employees
2.7K
Website
Sectors
Financials (LTM)
EV
$5B
Valuation Multiples
Start free trialClaritev Financials
Claritev reported last 12-month revenue of $976M and EBITDA of $605M.
In the same LTM period, Claritev generated $719M in gross profit, $605M in EBITDA, and had net loss of ($276M).
Revenue (LTM)
Claritev P&L
In the most recent fiscal year, Claritev reported revenue of $965M and EBITDA of $603M.
Claritev is unprofitable as of last fiscal year, with gross margin of 67%, EBITDA margin of 62%, and net margin of (29%).
Financial data powered by Morningstar, Inc.
Claritev Stock Performance
Claritev has current market cap of $483M, and enterprise value of $5B.
Market Cap Evolution
Claritev's stock price is $28.34.
Claritev share price increased by 12.8% in the last 30 days, and decreased by 37.1% in the last year.
Claritev has an EPS (earnings per share) of $-16.68.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5B | $483M | 5.0% | 12.8% | 73.4% | -37.1% | $-16.68 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialClaritev Valuation Multiples
Claritev trades at 5.3x EV/Revenue multiple, and 8.6x EV/EBITDA.
EV / Revenue (LTM)
Claritev Financial Valuation Multiples
As of June 3, 2026, Claritev has market cap of $483M and EV of $5B.
Claritev has a P/E ratio of (1.8x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Claritev Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Claritev Margins & Growth Rates
Claritev grew revenue by 3% and EBITDA by 1% in the last fiscal year.
In the most recent fiscal year, Claritev reported gross margin of 67%, EBITDA margin of 62%, and net margin of (29%).
Claritev Margins
Claritev Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Claritev Operational KPIs
Claritev's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.3M for the same period.
Claritev's Rule of 40 is 64% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Claritev's Rule of X is 68% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
Claritev Competitors
Claritev competitors include Weave Communications, Heren Health, GPI Group, Veradigm, Guiyang Longmaster, Shanghai Wondertek, Artrya, Medley Inc., WingArc1st and Beijing Sunwayworld.
Most Claritev public comparables operate across Healthcare Software, BI & Analytics Software, B2B SaaS, Vertical SaaS, HealthTech, Horizontal SaaS and Longevity.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.9x | 1.8x | 58.8x | 39.0x | |||
| 6.5x | - | 34.9x | - | |||
| 1.4x | 1.3x | 6.7x | 6.4x | |||
| - | 0.5x | - | 3.4x | |||
| 10.8x | - | 85.6x | - | |||
| 11.0x | - | 105.5x | - | |||
| 24054.7x | 164.7x | (50.1x) | (34.8x) | |||
| 1.9x | 1.7x | 14.5x | 13.4x | |||
This data is available for Pro users. Sign up to see all Claritev competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by Claritev
Claritev has acquired 3 companies to date.
Last acquisition by Claritev was on May 9th 2023. Claritev acquired Benefits Science for $160M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by Claritev
| Description | Benefits Science is a Denver-based software provider offering predictive analytics for self-insured health plans. The platform employs machine learning algorithms and actuarial models to forecast claims, recommend optimized medical benefits, and assess plan performance against employer budgets. Clients include large self-funded employers and TPAs who use its tools to cut costs by up to 15 percent while improving member care quality. Founded in 2017, Benefits Science integrates with claims data from major carriers like Cigna and Blue Cross Blue Shield. | Discovery Health Partners is a provider of payment integrity and revenue optimization software for health insurance payers. Franklin, Tennessee-headquartered, it deploys analytics platforms for claims auditing, overpayment recovery, DRG validation, and government program reimbursements including Medicare Advantage and Medicaid. | HST is a provider of value-based payment technologies for healthcare since 2009, headquartered in the United States. It offers pricing benchmarks and analytics software to determine medical service values, supporting insurers and employers with cost transparency tools for surgical procedures, imaging, and outpatient care. |
| HQ Country | |||
| HQ City | Boston, MA | Chicago, IL | Los Angeles, CA |
| Deal Date | 9 May 2023 | 21 Jan 2021 | 10 Nov 2020 |
| Valuation | $160M | $155M | $140M |
| EV/Revenue | |||
| EV/EBITDA | |||
This data is available for Pro users. Sign up to see all Claritev acquisitions and their M&A valuation multiples. Start Free Trial | |||
Investments by Claritev
Claritev has invested in 2 companies to date.
Latest investment by Claritev was on June 16th 2022. Claritev invested in Abacus Insights in their $41M Series C round (EV/Revenue multiple available to Pro users).
Latest Investments by Claritev
| Description | - | DocASAP is a Virginia-headquartered patient engagement platform founded in 2012, serving health systems, payers, and physician groups. It facilitates intelligent provider-patient matching for streamlined access, care compliance, and population health management, fostering payer-provider connections to lower costs and enhance outcomes. |
| HQ Country | ||
| HQ City | - | Washington, DC |
| Deal Date | 16 Jun 2022 | 5 Sep 2013 |
| Round | Series C | Seed |
| Raised | $41M | $800K |
| Investors | .406 Ventures; Claritev; CRV; Echo Health Ventures; Horizon Healthcare Services; The Blue Venture Fund | Blueprint Health; Claritev |
| Valuation | undisclosed | undisclosed |
| EV/Revenue | ||
| EV/EBITDA | ||
This data is available for Pro users. Sign up to see all Claritev investments and their VC round multiples. Start Free Trial | ||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Claritev
| When was Claritev founded? | Claritev was founded in 2019. |
| Where is Claritev headquartered? | Claritev is headquartered in United States. |
| How many employees does Claritev have? | As of today, Claritev has over 2K employees. |
| Who is the CEO of Claritev? | Claritev's CEO is Travis S. Dalton. |
| Is Claritev publicly listed? | Yes, Claritev is a public company listed on NYSE. |
| What is the stock symbol of Claritev? | Claritev trades under CTEV ticker. |
| When did Claritev go public? | Claritev went public in 2020. |
| Who are competitors of Claritev? | Claritev main competitors include Weave Communications, Heren Health, GPI Group, Veradigm, Guiyang Longmaster, Shanghai Wondertek, Artrya, Medley Inc., WingArc1st, Beijing Sunwayworld. |
| What is the current market cap of Claritev? | Claritev's current market cap is $483M. |
| What is the current revenue of Claritev? | Claritev's last 12 months revenue is $976M. |
| What is the current revenue growth of Claritev? | Claritev revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Claritev? | Current revenue multiple of Claritev is 5.3x. |
| What is the current EBITDA of Claritev? | Claritev's last 12 months EBITDA is $605M. |
| What is Claritev's EBITDA margin? | Claritev's last 12 months EBITDA margin is 62%. |
| What is the current EV/EBITDA multiple of Claritev? | Current EBITDA multiple of Claritev is 8.6x. |
| What is the current FCF of Claritev? | Claritev's last 12 months FCF is ($5M). |
| What is Claritev's FCF margin? | Claritev's last 12 months FCF margin is (1%). |
| What is the current EV/FCF multiple of Claritev? | Current FCF multiple of Claritev is (1012.2x). |
| How many companies Claritev has acquired to date? | As of June 2026, Claritev has acquired 3 companies. |
| What was the largest acquisition by Claritev? | $160M acquisition of Benefits Science on 9th May 2023 was the largest M&A Claritev has done to date. |
| What companies Claritev acquired? | Claritev acquired Benefits Science, Discovery Health Partners, and HST. |
| In how many companies Claritev has invested to date? | As of June 2026, Claritev has invested in 2 companies. |
| What was the last Claritev investment? | On 16th June 2022 Claritev invested in Abacus Insights, participating in a $41M Series C round, alongside .406 Ventures, CRV, Echo Health Ventures, Horizon Healthcare Services, and The Blue Venture Fund. |
| In what companies Claritev invested in? | Claritev invested in Abacus Insights and DocASAP. |
See public comps similar to Claritev
Lists including Claritev
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
